Key facts
- NeuroHarmonics’s last known valuation is $7.5M (Dec 2024).
- It has raised $2.1M; the latest was Seed Round ($2.1M) in Dec 2024.
- Notable investors include Speedinvest.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for NeuroHarmonics
- ·The full record, as it builds
Funding rounds
No funding rounds for NeuroHarmonics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NeuroHarmonics
Developer of a neurotechnology platform designed to non-invasively treat and interface with the brain using next-generation ultrasound. The company offers a wearable device that uses precisely focused sound waves to modulate specific brain circuits, enabling patients with a treatment of neurological and psychiatric conditions in the home.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2024
- Employees
- 8
- Website
- neuroharmonics.com/
- Ownership
- Privately Held (backing)
NeuroHarmonics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NeuroHarmonics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NeuroHarmonics in its N-PORT filings yet. We sweep new filings monthly.